BioRender 图标

Syringe (large, 1/2 liquid)

Syringe (large, 1/2 liquid) - Editable icon of A large syringe with 1/2 liquid filled
[{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c793/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c793/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c794/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c794/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c795/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c795/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c796/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c796/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c797/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c797/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c798/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c798/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c799/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c799/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79a/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79a/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79b/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79b/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79c/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79c/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79d/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79d/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79e/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79e/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c79f/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c79f/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a0/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a0/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a1/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a1/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a2/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a2/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a3/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a3/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a4/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a4/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a5/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a5/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a6/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a6/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a7/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a7/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a8/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a8/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7a9/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7a9/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7aa/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7aa/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7ab/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7ab/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7ac/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7ac/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7ad/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7ad/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7ae/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7ae/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7af/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7af/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b0/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b0/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b1/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b1/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b2/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b2/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b3/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b3/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b4/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b4/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b5/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b5/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b6/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b6/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b7/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b7/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b8/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b8/5f63cda719623700288c697d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b1a20a611cd8db18c7b9/5f63cda719623700288c697d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b1a20a611cd8db18c7b9/5f63cda719623700288c697d.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
syringe,needle,injection,inject,vaccine,vaccination,barrel,medicine,drug,gavage,needle,syringe
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Syringe (large, 1/2 liquid) icon JPEG

Syringe (large, 1/2 liquid) icon PNG

Syringe (large, 1/2 liquid) icon SVG

Syringe (large, 1/2 liquid) icon GIF

BioRender 图标常见问题解答

How are scientists using the Syringe (large, 1/2 liquid) icon in their work?

BioRender users often use the Syringe (large, 1/2 liquid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Syringe (large, 1/2 liquid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Syringe (large, 1/2 liquid) icon customizable in BioRender?

Most icons in BioRender, including the Syringe (large, 1/2 liquid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Syringe (large, 1/2 liquid) icon for publication or presentations?

Yes, figures containing the Syringe (large, 1/2 liquid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Syringe (large, 1/2 liquid) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Syringe (large, 1/2 liquid) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Syringe (large, 1/2 liquid) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon